Novel Multipotent Tacrine−Dihydropyridine Hybrids with Improved Acetylcholinesterase Inhibitory and Neuroprotective Activities as Potential Drugs for the Treatment of Alzheimer's Disease

In this work we describe the synthesis and biological evaluation of the tacrine−1,4-dihydropyridine (DHP) hybrids (3−11). These multipotent molecules are the result of the juxtaposition of an acetylcholinesterase inhibitor (AChEI) such as tacrine (1) and a 1,4-DHP such as nimodipine (2). Compounds 3−11 are very selective and potent AChEIs and show an excellent neuprotective profile and a moderate Ca²⁺ channel blockade effect. Consequently, these molecules are new potential drugs for the treatment of Alzheimer's disease.